U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07855991) titled 'A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Sonrotoclax in Participants With Severe Hepatic Impairment' on Sept. 29.
Brief Summary: The goal of this study is to understand how the body processes sonrotoclax in adults with serious liver problems compared to adults with normal liver function.
Study Start Date: Oct. 15
Study Type: INTERVENTIONAL
Condition:
Hepatic Impairment
Healthy Adult Participants
Intervention:
DRUG: Sonrotoclax
Single dose administered orally.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: BeOne Medicines
Disclaimer: Curated by HT Syndication....